Education
About Us
Working with TipRanks
Follow Us
Mosaic Immunoengineering Inc (CPMV)
:CPMV
Total Valuation
Mosaic ImmunoEngineering has a market cap or net worth of $3.69M. The enterprise value is ―.
Market Cap$3.69M
Enterprise Value―
Share Statistics
Mosaic ImmunoEngineering has 7,242,137 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,242,137
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Mosaic ImmunoEngineering’s return on equity (ROE) is 0.49 and return on invested capital (ROIC) is 71.93%.
Return on Equity (ROE)0.49
Return on Assets (ROA)-9.11
Return on Invested Capital (ROIC)71.93%
Return on Capital Employed (ROCE)0.72
Revenue Per Employee0.00
Profits Per Employee-1.19M
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Mosaic ImmunoEngineering is ―. Mosaic ImmunoEngineering’s PEG ratio is 0.08.
PE Ratio―
PS Ratio0.00
PB Ratio-1.47
Price to Fair Value-1.47
Price to FCF-10.38
Price to Operating Cash Flow-7.84
PEG Ratio0.08
Income Statement
In the last 12 months, Mosaic ImmunoEngineering had revenue of 0.00 and earned -2.38M in profits. Earnings per share was -0.33.
Revenue0.00
Gross Profit0.00
Operating Income-2.63M
Pretax Income-2.38M
Net Income-2.38M
EBITDA-2.28M
Earnings Per Share (EPS)-0.33
Cash Flow
In the last 12 months, operating cash flow was -564.24K and capital expenditures 0.00, giving a free cash flow of -564.24K billion.
Operating Cash Flow-564.24K
Free Cash Flow-564.24K
Free Cash Flow per Share-0.08
Dividends & Yields
Mosaic ImmunoEngineering pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.31
52-Week Price Change-43.33%
50-Day Moving Average0.63
200-Day Moving Average0.64
Relative Strength Index (RSI)45.32
Average Volume (3m)1.78K
Important Dates
Mosaic ImmunoEngineering upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Mosaic ImmunoEngineering as a current ratio of 0.07, with Debt / Equity ratio of -25.15%
Current Ratio0.07
Quick Ratio0.07
Debt to Market Cap0.17
Net Debt to EBITDA-0.44
Interest Coverage Ratio-17.33
Taxes
In the past 12 months, Mosaic ImmunoEngineering has paid 2.40K in taxes.
Income Tax2.40K
Effective Tax Rate>-0.01
Enterprise Valuation
Mosaic ImmunoEngineering EV to EBITDA ratio is -3.58, with an EV/FCF ratio of -11.84.
EV to Sales0.00
EV to EBITDA-3.58
EV to Free Cash Flow-11.84
EV to Operating Cash Flow-11.84
Balance Sheet
Mosaic ImmunoEngineering has $252.90K in cash and marketable securities with $1.30M in debt, giving a net cash position of -$1.04M billion.
Cash & Marketable Securities$252.90K
Total Debt$1.30M
Net Cash-$1.04M
Net Cash Per Share-$0.14
Tangible Book Value Per Share-$0.68
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Mosaic ImmunoEngineering is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―